Offering scalable digital therapy that delivers guided behavioral interventions for chronic pain management via a prescription smartphone platform.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Swing Therapeutics develops prescription digital therapeutics focused on chronic pain conditions, particularly fibromyalgia, delivering smartphone‑based behavioral therapy grounded in Acceptance and Commitment Therapy. The company integrates clinically validated, self‑guided ACT programs with its specialty virtual clinic to expand access to non‑drug pain management and holistic fibromyalgia care.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Investors
AME Cloud Ventures
Metrodora Venture Capital
JAZZ Venture Partners
Kicker Ventures
Asahi-Kasei Corporation
Mana Ventures
Gaingels Syndicate
Alumni Ventures Group
Swing Therapeutics Valuations & Financials
View real-time NPM data on Swing Therapeutics stock including daily Swing Therapeutics stock price estimates, valuation history, and historical share price information. Access Swing Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Swing Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Swing Therapeutics? Get in touch to learn more.
Similar Companies
like Swing Therapeutics
FAQ
We have answers
Swing Therapeutics stock does not trade on public stock exchanges. Swing Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Swing Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Swing Therapeutics Stock does not trade on public stock exchanges. In order to sell Swing Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Swing Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Swing Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Swing Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Swing Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Swing Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Swing Therapeutics is a private company and has not had an IPO. There is currently no Swing Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Swing Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
